Reproductive health shapes mental health throughout a woman's life — from the start of menstruation through menopause. This wide-ranging review brings together current evidence on how different reproductive events relate to mental well-being, with PMDD receiving significant attention.
For those living with PMDD, several important findings stand out. When diagnosed using prospective daily symptom tracking over two menstrual cycles (the gold standard), about 1.6% of menstruating people meet criteria for PMDD, though retrospective self-report suggests closer to 7.7%. The condition appears to be driven not by abnormal hormone levels, but by an unusual sensitivity to the normal rise and fall of hormones during the menstrual cycle. Research shows that when hormone fluctuations are completely suppressed, PMDD symptoms resolve — but reintroducing either estrogen or progesterone brings them back. SSRIs (a type of antidepressant) work well for PMDD and appear to act through a different mechanism than they do for depression, taking effect within about 48 hours rather than weeks. They are equally effective when taken only during the luteal phase (the roughly two weeks before a period) as when taken every day.
The review also highlights that PMDD-related sensitivity to hormonal changes may be part of a broader pattern. People who experience PMDD may also be more vulnerable to depression during peri-menopause (the years leading up to menopause), when hormone levels fluctuate significantly. Population studies show a two- to four-fold increase in new depression during peri-menopause, especially among those with a history of hormonally-linked mood changes.
Importantly, the time around menstruation carries increased risk for suicidal behavior across mental health conditions — not just PMDD. The menstrual phase was associated with a 17% higher risk of suicide attempts and a 26% higher risk of completed suicide. The authors emphasize that healthcare providers should routinely ask about the relationship between menstrual cycles and mental health symptoms, as this remains an area where opportunities for better care are frequently missed.
Key findings
- PMDD point prevalence is 1.6% when using prospective tracking over two cycles, rising to 7.7% with retrospective reporting of symptoms
- SSRIs for PMDD show a standardized mean difference of 0.65, larger than for depression, with peak effect at 48 hours and equal efficacy when dosed intermittently (luteal phase only) versus continuously
- The perimenstrual phase is associated with a 17% greater risk of suicide attempts, 26% greater risk of suicide deaths, and 20% greater risk of psychiatric admission compared to other cycle phases
- Peri-menopause (but not post-menopause) is associated with a 2- to 4-fold increase in new-onset major depressive disorder, with depressive symptoms correlating with hormonal fluctuations rather than absolute hormone levels
- Women with PCOS have increased risk of depression (ORs 2.6-3.8) and anxiety (ORs 2.7-5.6), and endometriosis is associated with increased depression (OR=1.9) and anxiety (OR=2.4)
- Multiple rigorous studies and reviews consistently conclude that abortion does not increase the risk of mental disorders, with pre-existing mental health conditions and other confounders explaining observed associations in flawed studies
Methods, briefly
Narrative review of existing literature spanning multiple reproductive life events and their relationship to mental health. The paper synthesizes findings from systematic reviews, meta-analyses, cohort studies, RCTs, and population-based registries. No primary data collection was conducted. Covers evidence from diverse global settings with particular attention to methodological quality of cited studies.
Limitations to keep in mind
- Narrative rather than systematic review methodology, with no formal quality assessment or risk of bias evaluation of included studies
- Most cited evidence comes from high-income countries, limiting generalizability to low- and middle-income settings
- Acknowledged that much of the evidence base on menstrual exacerbation of mental disorders is limited by methodological problems including retrospective recall, inadequate measurement of cycle phase, and between-person rather than within-person designs
- The paper does not cover pregnancy and postpartum mental health, which were addressed in a separate publication
- Evidence on interventions for many of the conditions discussed (e.g., compulsive sexual behaviour disorder, reproductive coercion) is described as sparse or lacking high-quality studies
The latest PMDD research, in your pocket
The app’s research feed is updated daily with newly published, peer-reviewed PMDD work - summarized in plain language.